Novo Nordisk to halve US list price of Wegovy from 2027 - Reuters
Novo Nordisk to halve US list price of Wegovy from 2027 Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNVTFMTVV0MFRtVjF5ZXlEbDBFR0NaZzdfVFVpRUViMllpOV9hZjJEY2lrY0VBbVJBQ015XzBKSHNDMm9uNzB3UkE3VlJUcGRkQlNGM3VOdnRyekp0NXY3MHhUNklnS0ctVnJJSlp1YnhGZlB2ajBOOU5WckJmWVA0NkdWbWNZNmtrTk1OSG9Rc0JvQUpGSUhCMmpmQXR0NUdJNUtPVHV5SGk5RUY0V19HX1ZwcXFDSWtKN3RseGZXMmI4QVdxS2JrdFZHYi0?oc=5" target="_blank">Novo Nordisk to halve US list price of Wegovy from 2027</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
China's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AMMore US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PMEli Lilly launches oral weight-loss pill Foundayo in UK - Reuters
Eli Lilly launches oral weight-loss pill Foundayo in UK Reuters
August 23, 2026 at 11:07 PMKimberly-Clark seeks EU approval for $40 billion Kenvue deal - Reuters
Kimberly-Clark seeks EU approval for $40 billion Kenvue deal Reuters
August 28, 2026 at 08:12 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AM